Results 281 to 290 of about 3,448,511 (303)
Some of the next articles are maybe not open access.

Extended-spectrum plasmid-mediated beta-lactamases.

The Journal of antimicrobial chemotherapy, 1996
Extended-spectrum beta-lactamases (ESBLs) are mutant enzymes which derive from TEM or SHV (class A) enzymes. They confer variable levels of resistance to cefotaxime, ceftazidime and other broad-spectrum cephalosporins and to monobactams such as aztreonam but have no detectable activity against cephamycins and carbapenems. Recently, new plasmid-mediated
openaire   +1 more source

Extended-Spectrum Beta-Lactamases

Seminars in Respiratory and Critical Care Medicine, 2003
Jan E Patterson
exaly  

Replicon typing of plasmids in Escherichia coli producing extended-spectrum beta-lactamases.

Journal of Antimicrobial Chemotherapy, 2009
G. Marcade   +7 more
semanticscholar   +1 more source

What's new in antibiotic resistance? Focus on beta-lactamases

Drug Resistance Updates, 2006
Robert A Bonomo, Andrea M Hujer
exaly  

Presence and distribution of extended-spectrum and AmpC beta-lactamases-producing on poultry farms in Slovenia

Journal of Applied Poultry Research, 2019
Irena Zdovc, Jaka Zgajnar, Alenka Dovc
exaly  

Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistant Pseudomonas aeruginosa in Riyadh, Saudi Arabia

Journal of Chemotherapy, 2012
Atef M Shibl   +2 more
exaly  

Extended-spectrum beta-lactamases in urinary tract infections caused by Enterobacteria: Understanding and guidelines for action

Actas Urológicas Españolas (English Edition), 2014
H Gimbernat, C Redondo, A García-Tello
exaly  

Home - About - Disclaimer - Privacy